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support clinical decisions and thereby providing the most
appropriate care for the patients. This system, which has well-
defIned criteria for organ failure, should be widely adopted to
allow inter-institutional comparisons. Scoring patients later in
their illness allows better predictability and decision-making
for individual patients, and to achieve maximum benefIt from
severity of illness scores these should be repeated on successive
days following admission if predictive decisions are to be made
in individuals.
Scoring of severity of illness is valuable for measuring the
standard of care in intensive care units. The APACHE II
scoring system is particularly well suited for this purpose,
since it is easy to perform and, done on admission, will allow
results of intensive care management to be compared nationally
and internationally. In addition, the results of different
therapies can be compared, because APACHE II accurately
predicts severity in illness in a large group of patients. It will
also be valuable in identifying problem areas and allowing
changes in therapy to be carefully monitored. For making a
decision regarding an individual patient, however, the organ
failure system is more valuable, using the defInitions of Knaus
er al. 5 and particularly if it is extended up to and beyond day
5. Both these systems should be adopted nationally to improve
the quality of intensive care in southern Africa. 7
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Back pain is one of the most common disorders seen in
general practice. Patients with chronic low back pain form a
large proportion of the work of any pain relief unit. The
aetiology of low back pain and the post-laminectomy pain
syndrome are briefly presented and treatment of the 'failed
back surgery patient' and the patient with arachnoiditis are
discussed.
S AIr Med J 1989; 76: 20-23.
Low back pain is a common complaint the world over. Patients
with intractable low back pain continue to plague pain relief
units. In the UK alone, back pain accounts for a total loss of
19 million working days per year. 1 In our unit, intractable
back pain accounts for 28% of patients treated. It cannot be
overemphasised how important it is to take a thorough history
and conduct an adequate clinical assessment of every patient
with low back pain.2 This enables the correct special investi-
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gations to be ordered, the diagnosis made and the treatment
planned in a logical and scientifIc way.
Aetiology of low back pain
Prolapsed intervertebral disc
This is a prolapse through the posterior longitudinal ligament
most commonly at L5-S 1, then L4-L5. In 90% of patients, the
pain improves markedly with 5 - 6 .weeks of strict bedrest.
Pelvic traction, physiotherapy, a corset and transcutaneous
electrical nerve stimulation are also used.3
If after 6 weeks the patient is no better, careful clinical
reassessment plus myelography needs to be carried out. If, on
myelography, a prolapsed disc is suspected, then computed·
tomography (CT) with intrathecal contrast outlining nerve
roots should be performed.4
Cauda equina claudication
Patients with this condition are usually over 60 years of age.
They suffer from sciatic pain and tingling on standing and
walking, but not on sitting or lying. They become virtual
prisoners in their own homes, and can only walk 50 - 100 m
before having to stop and sit down.. A myelogram will show
marked stenosis due to lumbar spondylosis superimposed on a
congenital stenosis. The treatment is a wide decompressive
laminectomy. If lumbar canal stenosis is found on myelography
and there is no pain, then surgery is not indicated.
Cauda equina tumours
These include neurofibromas, meningiomas and ependy-
momas (e.g. from filum terminale). Tumour can present as
back pain plus sciatica or just with incontinence, or with
wasted legs without pain. When pain occurs, it can be without
signs, and these patients are often labelled neurotic. The pain
is, however, characteristic. It is worse by night, and awakens
them. Typically, they get out of bed, walk around, then sit in a
chair in an attempt to relieve the pain.
Lumbar spondylosis or lateral gutter
syndrome
There is progressive degeneration of the intervertebral disc
leading to changes in the adjacent vertebra and ligaments.
Lipping and osteophytic formation occurs leading to narrowing
of intervertebral foramina. Flashes of pain occur with odd
movements with or without wasting and sensory loss. Super-
imposed on a congenital narrowed spinal canal, the clinical
symptoms become worse.2 Treatment is, firstly, conservative,
aiming at strengthening back muscles. If this fails, then a
decompressive laminectomy should be carried our.
Spinal angioma
This occurs as twisted blood vessels, usually in the posterior
mid-thoracic region. It presents as atypical cauda equina claudi-
cation. Pain occurs with sitting as well as with standing. It is
diagnosed by thoracic myelography, and can be missed if only
lumbar myelography is performed.
Others
Bony metastases occur from carcinoma of the breast,
prostate, lung, kidney, thyroid and gastro-intestinal tract. These
can cause spinal nerve root compression. Radio-active isotopic
bone scans and whole-body CT are used for diagnosis. Rarer
malignant conditions include myeloma, which often presents
as osteoporosis and sarcoma.
Spondylolisthesis is caused by congenital disruption of
the pars interarticularis with the shifting of one vertebra on
another. It may present as back pain that is cured by lying
down. Treatment for this instability is spinal fusion.
Other rarer causes of backache are osteoporosis, infections
(tuberculous or non-tuberculous) and entrapment neuropathies
(e.g. the sciatic nerve).
Post-laminectomy pain syndrome
The 'failed back surgery patient'
This group of patients should never have had surgery in the
first place. They may well have had 6 weeks of pain relief
(probably a placebo response) before the pain recurred. Each
operation makes them worse. In order to prevent this, it must
be remembered that if the causes of back pain and sciatica are
not known, then surgery should not be performed.
Prolonged postoperative pain
This may be the result of a disc protrusion not being
adequately removed or an operation performed at the wrong
level and the prolapsed disc not found. There may have been
two discs and only one was removed or disc prolapse was not
the cause but a neurofibroma (e.g. at top of the conus), spinal
angioma or an arachnoid hernia was present.
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Recurrent prolapsed intervertebral disc
Here, the patient presents with backache and sciatica, and a
prolapsed disc is found on myelography. A laminectomy is
performed with pain relief for 2 - 3. years and then the pain
returns. This may be the result of a prolapsed disc higher or
lower than the original one. Myelography should be performed
and the offending disc then removed.
Arachnoiditis
This occurs after repeated myelography, repeated disc sur-
gery and fusions. Iophendylate myelogtaphy in particular has
been implicated, although it does occur with other dyes. This,
plus rough surgery with intrathecal bleeding, causes intrathecal
adhesions on the nerve roots and the spinal cord. It is usually
diagnosed radiographically with myelography, CT or nuclear
magnetic resonance imaging (NMRI) since clinical signs and
symptoms vary.4 It has become the scrapheap diagnosis for the
'failed back surgery patient'. It is an unpleasant condition with
no cure. Patients often experience burning pain, which is
made worse by exercise. It is often ineradicable. Patients may
later develop numbness and weakness.
Treatment of the 'failed back surgery patient'
and the arachnoiditic patient
Treat the cause
If the wrong disc was removed, remove the correct one. If
the wrong diagnosis was made, remove the real cause - such
as a neurofibroma, spinal angioma or arachnoid hernia.
Physiotherapy
Extension back exercises. These restore the strength of
back muscles after prolonged bedrest or the use of a corset.
They break the cycle of muscle wasting, inactivity, more pain,
more inactivity and more muscle wasting. Exercises need to be
started slowly morning and evening and built up gradually
with time.
Hydrotherapy. Here the support of the water is used
during exercise.
Continued back care. Patients need to be taught not to
lift heavy items, to bend their knees and to keep their backs
straight when lifting anything, and to sit in chairs that support
the spine.s
Epidural corticosteroids plus local anaesthesia
A mixture of 0,5% bupivacaine (Marcaine; Saphar-Med)
and 40 mg (1 ml) methylprednisolone (Depo-Medrol; Upjohn)
is used. The earlier pain is treated, the better the relief. A
nvo-eatheter technique is used - one inserted into the epidural
space in the thoracolumbar region above the laminectomy scar
and one inserted through the caudal hiatus into the sacral
epidural space. Top-ups can be given daily for a toral of 3
doses.
Corticosteroids have a membrane-stabilising effect on abnor-
mal pain conduction. In addition, they have anti-inflammatory
properties and relieve pain associated with nerve and spinal
cord compression. It is important not to exceed 120 mg (3 x 40
mg) of methylprednisolone to avoid systemic side-effects.
Facet nerve blocks
The indication for a facet nerve block is low back pain
radiating to the buttock. Pain is usually worse with sitting and
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standing, and bener from sining to standing, or when walking.
Radiography is often unhelpful. A diagnostic facet block is
first performed by injecting a mixture of corticosteroid and
local anaesthetic into the facet joint.
If this works, the block can be made semipermanent by use
of a cryotherapy probe, which gives 6 - 8 weeks of good pain
relief, or a radiofrequency probe anacking either the facet joint
itself or the nerve to the facet joint at the base of the
transverse process.6
Injection of trigger points
Trigger points are areas of localised muscle spasm or of
referred pain. They can be part of a myofacial syndrome, and
need to be carefully identified and injected with a mixture of
local anaesthetic and corticosteroid. This injection helps to
decrease the total afferent barrage of pain. A dextrose-glycerine·
phenol solution has also been successfully used recently as an
injection into specific fascial and ligamentous sites in patients
with chronic low back pain.7
Antidepressants and anticonvulsants
Antidepressants have a direct analgesic action by inter-
fering with serotonin uptake in the descending amine pathway.
In addition, they act as mood elevators. Amitryptiline (Tryp-
tanol; Logos) is the most common tricyclic used. It is given in
a dosage of 2 or 3 times a day or 75 mg at night. Amitryptiline
can be combined with a phenothiazine, such as perphenazine,
in the combination called Etrafon-D; Scherag). Mianserin
(Lantanon; Donmed (Organon)), is the most common tetracyclic
antidepressant used. Its tetracyclic structure ensures less anti-
cholinergic side-effects, but it is a sedative and is thus given an
hour before bedtime in a dose of 30 mg. This dispenses with
the need for a benzodiazepine hypnotic at night. Other anti-
depressants used include imipramine (Tofranil; Geigy), clomi-
pramine (Anafranil; Geigy), dothiepin (Prothiadin; Boots) and
maprotiline (Ludiomil; Ciba).
Anticonvulsants have membrane-stabilising properties and
are used to stabilise abnormal conduction on pain tracts. The
lowest blood level necessary for the therapeutic control of
epilepsy is needed for the control of pain. Clonazepam (Rivotril;
Roche) is a benzodiazepine with a wide therapeutic index, and
no blood levels are needed for therapeutic control. A major
side-effect is sedation and treatment should begin with a small
dose of 0,5 mg twice a day working up to 1 mg 3 times a day
over 4 weeks. Sodium valproate (Epilim; Labaz) is another
anticonvulsant used. The dosage is 200 mg 2 - 4 times a day in
adult patients and a therapeutic blood level of at least 60 .ug/l
should be aimed at. If carbamazepine (Tegretol; Geigy) is
used, the starting dose is 100 mg/d for an adult, increasing by
100 mg every 4 days to a maximum of 400 mg/d. The
therapeutic blood level aimed at is at least 4 .ug/ml. With the
use of phenytoin sodium (Epanutin; Parke-Davis) the initial
dose is 100 mg/d in adults, increasing by 25 mg increments to
a maximum of 300 mg/d. The therapeutic blood level aimed at
is_ at least 10 .ug/ml.
Other adjuvant drugs. Pyridoxine (Beesix; Lennon) is
vitamin B6 and is said to increase encephalin release. It is
given in a dose of 25 mg 3 times a day for at least 6 weeks.
L-lrypwphan is a serotonin precursor and is said to release
endorphins from the pituitary gland. It is given in a dose of
500 - 1 000 mg 4 times a day. L-dopa and lilhium carbonate have
a number of side-effects and must be carefully controlled.
Combinations of antidepressants and anticonvulsants
need to be given a trial of at least 6 weeks: (I) mianserin 30 mg
at night plus clonazepam 0,5 mg twice a day to 1 mg 3 times a
day over 4 weeks; (il) amitryptiline 25 mg 3 times a day and
sodium valproate 200 mg twice a day to 200 mg 4 times a day;
and (iil) amitryptiline 25 mg 3 times a day and carbamazepine
100 - 400 mg Id.
Use of drugs for muscle spasm pain
Diazepam (Valium; Roche). This benzodiazepine increases
the efficiency of l'-aminobutyric acid (GABA)-ergic synapses
by acting on specific benzodiazepine receptors in the central
nervous system. In addition, it causes muscle relaxation from
inhibition of polysynaptic reflexes in· the spinal cord. The
dosage is 2 - 5 mg 3 times a day. It should be used for a short
period of time only.
Baclofen (Lioresal; Ciba) is a GABA derivative. It exerts
GABAB agonism mainly at spinal cord level. Dosage is between
30 mg and 75 mg daily, starting with 5 mg 3 times daily and
slowly working upwards.
Dantrolene (Dantrium; SK & F) decreases the release or
increases the sequestration of Ca++ from the lateral sacs of the
sarcoplasmic reticulum. It is contraindicated in acute hepatic
disease. Dosage is between 25 mg and 50 mg daily.
Orphenadrine (Norflex; Riker) blocks muscarinic
cholinergic receptors and is given in a dosage of 100 mg twice
daily. It has anticholinergic side-effects.
Treatment of arachnoiditis
Three injections of epidural 0,5% bupivacaine and 40
mg methylprednisolone. The two-catheter technique may
be more effective in gening the corticosteroid to the damaged
pain tracts.
Epidural clonidine (Catapres; Boehringer Ingelheim). 150
.ug of clonidine is diluted to 5 ml with normal salipe. It is used
with 50 mg of lignocaine to confirm its presence in the
epidural space. It works in approximately 25% of patients with
deafferentation pain (c. J. Glynn - personal communication,
1987). If effective at spinal cord level, the patient is maintained
on oral clonidine (Dixarit; Boehringer Ingelheim) 25 - 50 .ug
twice a day.
Epidural buprenorphine (Temgesic; R & C). Bupre-
norphine is a mu partial agonist which is 25 - 55 times more
potent than morphine. It has also been found to decrease
muscle spasm in paraplegics when given intrathecally (c. J.
Glynn - personal communication, 1987). It thus could be a
GABA agonist or have some specific effect of its own.
Buprenorphine 0,3 mg is diluted to 5 ml with normal saline
and injected into the epidural space over the affected nerve
roors. If effective at spinal cord level, maintenance with a
sublingual tablet 200 .ug 8-hourly is used. The sublingual
preparation is not yet available in South Africa.
Epidural morphine. Morphine 5 mg is diluted to 5 ml
with normal saline and injected into the epidural space over
the affected nerve roots. Side-effects include pruritus, nausea,
vomiting and urinary retention. If effective at a spinal cord
level, maintenance with MST Continus (Keatings), starting
with 10 mg twice a day is used.
It must be noted that sublingual buprenorphine and oral
morphine should only be used as last resorts to temporarily
maintain control over the patient's pain while other methods
are tried. The dangers of physical addiction are carefully
explained to the patient beforehand, as well as the side-effects
of opiates. This regimen should not be forced on the patient
and should not last longer than a few weeks.
Intrathecal baclofen relieves pain as well as muscle spasm.
The mechanism is unknown. The intravenous preparation is,
however, not available in South Africa.
Psychological support, evaluation and
psychotherapy
Many patients with low back pain suffer from severe depres-
sion. They can be aggressive towards the medical profession.
Frequently, they have been 'doctor-shopping' or have been
handed from one doctor to another with little improvement -
or even worsening - in their condition. Their plight has not
only affected their own lives, but also their family. These
patients thus need a great deal of understanding and suppon
and a clinical psychologist is vital for their evaluation. They
are placed on a pain management programme to teach them
relaxation therapy, distraction techniques and how to live with
their pain. Depression must be actively treated. An occupational
therapist is used to help in rehabilitation.
Transcutaneous electrical stimulation
Electrical stimulation of the skin at non-painful levels
increases activity along larger myelinated fibres, thus 'closing
the gate'. There is also evidence that transcutaneous electrical
stimulation causes the release of encephalins at the spinal cord
level. The patients are loaned electrical stimulation machines
to try for at least 6 weeks. They are taught to vary the position
of the electrodes as well as the intensity and frequency of the
current. This method is generally very safe. Occasionally,
allergy to the electrode, tape or gel occurs.
Dorsal column stimulation
This can be used if the patient responds well to transcu-
taneous electrical stimulation. An epidural electrode is used.
'Gosing the gate' occurs. Good results have been obtained in
60% of patients with arachnoiditis, but there is no lasting relief
after 1 year. (P. Teddy - personal communication, 1987).
Acupuncture
This needs to be performed at regular intervals, preferably
in group sessions.
Deep brain stimulation
There are few indications for deep brain stimulation. It is
usually applied in de-afferentation pain, where an electrode is
inserted into the ventroposteromedial nucleus of the thalamus,
or the peri-aqueduetal grey area.
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Analgesia
First-line drugs
Paracetamol (Panado; Saphar-Med). Dosage is 500 - I 000
mg every 4 - 6 hours. This is better tolerated than aspirin,
provided that total daily dose does not exceed 6 g, so as to
prevent free radical scavenger depletion.
Paracetamol 325 mg plus propoxyphene napsalate
(Distalgesic; Eli Lilly) 50 mg. Dosage is I - 2 tablets 4 - 6-
hourly.
Paracetamol 320 mg, caffeine 32 mg, codeine phos-
phate 8 mg, meprobomate 150 mg (Stopayne; Rio). Dosage
is 2 tablets 4 - 6-hourly.
Non-steroidal anti-inflammatory drugs
The top dose should be used. Failure is usually apparent by
7 days, and if this occurs, other classes should be tried.
Nefopam (Acupan; Riker)
Acupan is a central non-opioid analgesic. It is thought to
prevent the re-uptake of biogenic amines. It does benefit a
small number of patients. Dosage is 30 - 60 mg 3 - 4 times
daily.
Strong opiates
Oral controlled-release morphine 10 - 30 mg twice a day or
sublingual buprenorphine 200 - 400 J.1g 8-hourly are used on a
temporary basis to break the pain cycle.
Conclusion
There are many pitfalls in the diagnosis and treatment of
patients with low back pain. The taking of a good history and
thorough clinical assessment at the first consultation is impera-
tive. The treatment should be planned in a scientific and
logical way. In order to prevent further suffering and economic
outlay in 'failed back surgery patients', management is best
undertaken at a specialised pain relief unit.
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